HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Arfaa, F. Articles by Ardelan, A. Search for Related Content PubMed PubMed Citation Articles by Arfaa, F. Articles by Ardelan, A.

Treatment of Urinary Bilharziasis in a Small Focus with Sodium Antimony Dimercaptosuccinate (Astiban®)^*

F. Arfaa, E. Tohidi AND A. Ardelan

A slow method of administering sodium antimony dimercaptosuccinate was tried in 163 cases of haematobium bilharziasis in an effort to reduce side-effects. The drug was given over a period of 2 weeks, the total amount being the same as tried previously in a short 5-day administration schedule.

The severity and number of side-effects were the same in both trials. However, the data suggest that the parasitologic rate of cure is reduced from 100% in the short schedule to 80% in the slow one.

^* These studies were supported by the Institute of Public Health Research, School of Medicine, Teheran University, and fundings of the Ministry of Health and Plan Organization for the WHO-assisted Bilharziasis Study and Research Project (Projects No. 777 and 63001).

Associate Professor, Institute of Public Health Research.

Epidemiologist, Institute of Public Health Research.

Senior Field Technician, Institute of Public Health Research.